CorVel Announces Revenues and Earnings
IRVINE, Calif., Aug. 4 /PRNewswire-FirstCall/ -- CorVel Corporation (Nasdaq: CRVL ) reported earnings per share of $0.49 for the quarter ended June 30, 2009, a 24% increase compared to $0.40 in the same quarter of the prior year. The Company reported quarterly revenues of $81 mill...CryoLife Reports Record Quarterly Revenues of $28.2 Million
ATLANTA, July 30 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY ) , an implantable biological medical device and cardiovascular tissue processing company, announced today that revenues for the second quarter of 2009 increased 4 percent to a quarterly record of $28.2 million compa...CorVel Announces Revenues and Earnings
IRVINE, Calif., June 4 /PRNewswire-FirstCall/ -- CorVel Corporation (Nasdaq: CRVL ) reported earnings per share of $0.33 for the quarter ended March 31, 2009, compared to $0.44 in the same quarter of the prior year. For the fiscal year ended March 31, 2009 earnings were $1.42 per share compared ...Nyer Medical Group, Inc. Reports Revenues of $18.6 Million for the Quarter Ended March 31, 2009
HOLLISTON, Mass., May 15 /PRNewswire-FirstCall/ -- Nyer Medical Group, Inc. (Nasdaq: NYER ) reported results for the Company's third quarter ended March 31, 2009. Revenues for third quarter of fiscal 2009 increased $1.3 million or 7.5% to $18.6 million from $17.3 million as reported for the com...Providence Service Corporation Announces Record Revenues and Earnings in the First Quarter of 2009
First Quarter Highlights: - Revenue gained 7.5% to $187 million compared to Q1 2008 - Net income increased 58.7% compared to Q1 2008, rising to $5.9 million, or $0.44 per diluted share - Increases in client census and rate combined with increased efficiencies in operations contribu...VirtualScopics Reports Record Revenues and Gross Profit in the First Quarter
1st quarter revenues grow by 31% and gross profit increases 85% ROCHESTER, N.Y., May 5 /PRNewswire-FirstCall/ -- VirtualScopics, Inc. (Nasdaq: VSCP ), a leading provider of quantitative imaging for clinical trials, announced today that revenues for the first quarter of 2009 were over $2.1 m...drugstore.com Reports Highest Net Revenues in Company History
- OTC, Vision and Beauty Sales Outpace Industry - Net Income of $1.3 Million and Adjusted EBITDA More Than Doubles Year-Over-Year to $5.6 Million BELLEVUE, Wash. April 29 /PRNewswire-FirstCall/ -- drugstore.com , inc. (Nasdaq: DSCM ), a leading online retailer of health, beauty, vis...Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter
Revenues Grow 115% Over Q1 2008 VANCOUVER, April 20 /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) today announced preliminary unaudited revenues for the three-month period ended March 31, 2009. First quarter revenues increased 115% to approximately $2.526 m...Nektar Therapeutics Reports Second Quarter 2009 Financial Results
... to revenue of $40.4 million in the first half of 2008. This decrease in revenue is primarily the result of lower contract research and manufacturing revenues resulting from the sale of certain of the company's pulmonary assets to Novartis which occurred on December 31, 2008. Cash, cash equivalents,...Covance Receives Highest Level of Phase I Accreditation
...ance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.7 billion, global operations in more than 25 countries, and more than 10,000 employees worldwide. Information on Covance's products an...Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
... operating divisions: Human Health, Animal Health, and Food Safety. The Company's primary goal is to develop proprietary cancer therapies supported by revenues from marketed products in human and animal health. Bioniche has been named one of the Top 50 Best Small and Medium-Sized Employers in Canada for 2009....Covance Announces Integrated Radiolabeled Clinical Pharmacology Studies
...ance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.7 billion, global operations in more than 25 countries, and more than 9,800 employees worldwide. Information on Covance's products and...EUCODIS Bioscience Achieves Development Milestone in Second Collaboration With Lohmann Animal Health
...nes for farm animals, contributing to a safe food supply. Based in Germany, LAH is active in major markets worldwide, with more than 70 percent of its revenues generated from export sales. The Company has more than 500 employees in Germany and the United States as well as in its subsidiaries and sales offices...Research: Popular Diabetes Medications Associated with Increase in Bone Fractures
...vate the practice of pharmacy -- a key element in reforming America's health care system. Medco is ranked number 45 on the Fortune 500 list, with 2008 revenues of more than $51 billion. For more information about Medco, go to http://www.medcohealth.com . This press release contains "forward-looking ...Greenhouse gas auction revenues can help cut Md. electric use significantly, says study
COLLEGE PARK, Md. Maryland officials can reduce electricity use in the state significantly by investing revenues from the Regional Greenhouse Gas Initiative (RGGI) cap-and-trade auctions in energy efficiency programs, says a new study from a University of Maryland-led research team. It adds that ...Aware, Inc. Reports Second Quarter 2009 Financial Results
...r its second quarter ended June 30, 2009. revenues for the second quarter of 2009 were $5.8 million, ...ast year. For the six months ended June 30, 2009, revenues decreased 14% to $10.3 million, compared to $12.0 ...id, "We are encouraged by the modest growth in our revenues this quarter. Our goal is to generate shareholder...Fujitsu Expands Support for Ethernet Networks With New Additions to XG Switch Product Line
...s products and advanced microelectronics to deliver added value to customers. Headquartered in Tokyo, Fujitsu Limited (TSE:6702) reported consolidated revenues of 4.6 trillion yen (US$47 billion) for the fiscal year ended March 31, 2009. For more information, please see: www.fujitsu.com . About Fuj...Frost & Sullivan: North American Government Biometrics Markets Thrive With Active R&D Thrust
... New analysis from Frost & Sullivan ( http://www.autoid.frost.com ), North American Government Biometrics Markets , finds that market earned revenues of over $2.60 billion in 2007 and estimates this to reach $9.44 billion in 2014. If you are interested in a virtual brochure, which provides ...Fujitsu PalmSecure Certified Under International Common Criteria Evaluation Assurance Level 2
...s products and advanced microelectronics to deliver added value to customers. Headquartered in Tokyo, Fujitsu Limited (TSE:6702) reported consolidated revenues of 4.6 trillion yen (US$47 billion) for the fiscal year ended March 31, 2009. For more information, please see: www.fujitsu.com . About F...New Report Just Published: World Solid-State, Fiber, Gas and Dye Lasers Market Report
...Players in Global Laser Industry (2007): Sales revenues for Trumpf, JDS Uniphase, Coherent, Rofin-Sina...s Market (2007): Percentage Breakdown of Sales revenues by End-Use - Industrial Material Processing, M...s Market (2008): Percentage Breakdown of Sales revenues by End-Use- Industrial Material Processing, R&...Rising acidity levels could trigger shellfish revenue declines, job losses
...CO 2 ) emissions from human industrial activity could cause U.S. shellfish revenues to drop significantly in the next 50 years, according to a new study by res...y sensitive to these changes. In a case study of U.S. commercial fishery revenues published in the June issue of Environmental Research Letters , WHOI scien...American Chemical Society weekly presspac -- June 10, 2009
...solar technology into the overall building aesthetic. One estimate suggests that the market for BIPV will grow by 18 percent a year through 2014, with revenues of about $780 million, according to the article. Japan and Europe are now the strongest markets for BIPV. Sales are just beginning to rise in the ...Equity concerns raised by congestion pricing can be addressed to make approach viable
...if a road construction bond was paid off with toll revenues rather than sales taxes, people in the lowest-inco...ther regressive or progressive. But if regions use revenues in ways that benefit low-income individuals, conge...cing is more likely to be progressive. If the toll revenues are used in other ways, then it can be regressive ...Sinobiopharma Updates on Progress; Projects Increases in Sales and Revenues In 2009
NANTONG CITY, China, May 20 /PRNewswire-FirstCall/ -- Sinobiopharma, Inc. (OTC Bulletin Board: SNBP) ("Sinobiopharma" or, the "Company") is pleased to provide an update on the Company's progress to date this year and guidance on its projected financial performance for the balance of 2009. Fin...CryoLife Reports Record First Quarter Revenues of $26.7 Million
Operating income increases 26 percent in first quarter of 2009 compared to 2008 ATLANTA, April 30 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY ) , an implantable biological medical device and cardiovascular tissue processing company, announced today that revenues for the first quart...Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008
NEW YORK, April 7 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. ("Biostar" or the "Company") (OTC Bulletin Board: BSPM) today reported financial results for the 12 months ended December 31, 2008. Highlights for Year Ended December 31, 2008: -- Total net sales for th...Kun Run Biotechnology, Inc. Year-End Revenues Increase 56% to $11.6 million
HAIKOU, China, April 1 /PRNewswire-Asia-FirstCall/ -- Kun Run Biotechnology, Inc., (OTC Bulletin Board: KURU) a leading bio-pharmaceutical company in China that focuses on manufacture and sales of peptides and peptide-based drugs, today announced its financial results for the year ended Decemb...CryoLife Reports Record Annual Revenues of $105.1 Million for FY 2008
ATLANTA, Feb. 19 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY ), an implantable biological medical device and tissue processing company, announced today that revenues for the year ended December 31, 2008 increased 11 percent to $105.1 million compared to $94.8 million for the year end...